IRulya Therapeutics Inc. (IRLA)

NASDAQ

$32.92

$+0.33

(+1.03%)

Regular Market

IRulya Therapeutics Inc. (IRLA) Live Price Chart

Last updated: ⁦2026-10-19 18:56:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

IRulya Therapeutics Inc. (IRLA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $32.92, with a market capitalization of $32.58M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $25.13 to $34.93. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$32.58M
Open	$31.17
Day's High	$34.93
Day's Low	$25.13
Previous Close	$32.03
Volume	36.56K
Average Volume	41.75K
P/E Ratio	--
52-Week High	$34.93
52-Week Low	$25.13
Dividend Yield	--
Earnings Date	--

IRulya Therapeutics Inc. (IRLA) Stock Price Today

IRulya Therapeutics Inc. (IRLA) is currently trading at $32.92 as of 2026-10-19 18:55:00, up 2.78% ($0.89) from the previous close of $32.03

During today's regular trading session, IRLA has traded between $25.13 and $34.93, with a trading volume of 36.56K shares. The current price is near the upper end of today's range.

IRulya Therapeutics Inc. (IRLA) 7-Day Stock Price Change

Over the past seven days, IRulya Therapeutics Inc. (IRLA) moved from $32.40 to $32.92, representing a gain of 1.60% ($0.52).

The stock traded between $25.13 and $34.93 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 41.75 thousand shares, -- versus the previous seven-day period, indicating -- trading activity.

IRLA 52-Week Price Position

Position in Range: 79.5%

52W Low$25.13

52W High$34.93

IRLA is currently trading at $32.92, placing it 79.5% of the way from its 52-week low of $25.13 to its 52-week high of $34.93. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is IRulya Therapeutics Inc. (IRLA)?

IRulya Therapeutics Inc is committed to transforming the lives of patients with serious, underserved diseases by developing disease-modifying therapies. The company is currently developing LAM-001 for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD), bronchiolitis obliterans syndrome post-lung transplant (BOS), and sarcoidosis-associated pulmonary hypertension (SAPH). A Phase 2a study in PH patients has been completed; a Phase 2 clinical study in BOS patients is ongoing; a Phase 2b clinical study in PH-ILD is ongoing; and a Phase 2 clinical study in SAPH is ongoing.

IRulya Therapeutics Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	38
Exchange	NASDAQ
Company Website	https://www.quincetx.com

How to Buy IRulya Therapeutics Inc. (IRLA) Stock on MEXC

Eligible investors can buy real shares of IRulya Therapeutics Inc. (IRLA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for IRLA and Place Your Order

Open the RealStocks trading page and search for IRLA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is IRulya Therapeutics Inc. (IRLA) stock price today?

IRulya Therapeutics Inc. (IRLA) is currently trading at $ 32.92, up 2.78% ($0.89) from the previous close of $ 32.03. Intraday prices update in real time during regular trading hours.

2.Is IRLA stock going up or down today?

As of 2026-10-19 18:55:00, IRLA is trading at $ 32.92, up 2.78% ($0.89) from its previous close of $ 32.03. The stock has traded between $ 25.13 and $ 34.93 during today’s regular session. Past price movements do not guarantee future results.

3.What is IRLA pre-market price?

As of 2026-10-19 18:55:00, IRLA is trading at $ 31.16 in pre-market trading, down 2.73% ($0.87) from the previous close of $ 32.03. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is IRLA after-hours price?

As of 2026-10-19 18:55:00, IRLA is trading at $ 31.40 in after-hours trading, down 1.97% ($0.63) from the regular-session close of $ 32.03. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is IRLA stock trading now?

IRLA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does IRLA sit relative to its 52-week high and low?

Over the past 52 weeks, IRLA has traded between a low of $ 25.13 and a high of $ 34.93. At $ 32.92, the stock is positioned 79.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is IRulya Therapeutics Inc. in?

IRulya Therapeutics Inc. (IRLA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is IRulya Therapeutics Inc.'s market capitalization and where is it listed?

IRulya Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 32.58M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is IRLA valued in terms of P/E ratio and EPS?

IRLA trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does IRulya Therapeutics Inc. pay a dividend?

IRulya Therapeutics Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.